4//SEC Filing
Williams Charles O 4
Accession 0001593968-25-000414
CIK 0001824893other
Filed
Mar 24, 8:00 PM ET
Accepted
Mar 25, 9:36 PM ET
Size
17.2 KB
Accession
0001593968-25-000414
Insider Transaction Report
Form 4
Williams Charles O
Chief Operating Officer
Transactions
- Disposition to Issuer
Series A Common Stock Warrant (right to buy)
2025-03-24−1,474→ 0 totalExercise: $16.96From: 2024-04-04Exp: 2029-04-04→ Common Stock (1,474 underlying) - Disposition to Issuer
Series B Common Stock Warrant (right to buy)
2025-03-24−1,603→ 0 totalExercise: $15.71From: 2024-04-04→ Common Stock (1,603 underlying) - Disposition to Issuer
Series D Common Stock Warrant (right to buy)
2025-03-24−5,712→ 0 totalExercise: $16.00→ Common Stock (5,712 underlying) - Award
Series A Common Stock Warrant (right to buy)
2025-03-24+1,474→ 1,474 totalExercise: $12.45From: 2024-04-04Exp: 2029-04-04→ Common Stock (1,474 underlying) - Award
Series B Common Stock Warrant (right to buy)
2025-03-24+1,603→ 1,603 totalExercise: $12.45From: 2024-04-04→ Common Stock (1,603 underlying) - Disposition to Issuer
Series C Common Stock Warrant (right to buy)
2025-03-24−5,712→ 0 totalExercise: $16.00→ Common Stock (5,712 underlying)
Footnotes (6)
- [F1]The warrant was repriced pursuant to a Warrant Cancellation and Amendment Agreement effective March 24, 2025 to decrease the per share exercise price of the warrant from $16.96 to $12.45.
- [F2]The warrant was repriced pursuant to a Warrant Cancellation and Amendment Agreement effective March 24, 2025 to decrease the per share exercise price of the warrant from $15.71 to $12.45.
- [F3]The warrant expires on the fifth trading day following the occurrence of the Series B Milestone Event (as defined in the Series B Common Stock Warrant). In the event the Series B Milestone Event has not occurred prior to the fifth anniversary of the issuance date of the warrant, the warrant will automatically terminate on such anniversary date.
- [F4]The warrant was cancelled pursuant to a Warrant Cancellation and Amendment Agreement effective March 24, 2025.
- [F5]The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series C Milestone Event (as defined in the Series C Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series C Common Stock Warrant).
- [F6]The warrant is exercisable for 30 days after the earlier of (i) the occurrence of the Series D Milestone Event (as defined in the Series D Common Stock Warrant) and (ii) a Fundamental Transaction (as defined in the Series D Common Stock Warrant).
Documents
Issuer
Surrozen, Inc./DE
CIK 0001824893
Entity typeother
Related Parties
1- filerCIK 0001325818
Filing Metadata
- Form type
- 4
- Filed
- Mar 24, 8:00 PM ET
- Accepted
- Mar 25, 9:36 PM ET
- Size
- 17.2 KB